share

9-Bromo-2-Iodo-10-Methyl-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepine CAS NO 1403766-75-5


Unit Price:

CAS No.:1403766-75-5

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

9-Bromo-2-Iodo-10-Methyl-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepine CAS NO 1403766-75-5 is a high-purity, heterocyclic organic compound featuring a complex fused ring system with halogen substituents. This specialized chemical building block is critical for advanced pharmaceutical research and development, particularly in medicinal chemistry. It serves as a key intermediate for synthesizing novel drug candidates, primarily targeting researchers and process chemists in the pharmaceutical, agrochemical, and fine chemical industries.

Application

  • Pharmaceutical Intermediate: A crucial building block for the synthesis of novel active pharmaceutical ingredients (APIs), especially in central nervous system (CNS) and oncology research.
  • Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for drug discovery programs.
  • Chemical Biology Probe Development: Serves as a scaffold for creating molecular probes to study biological pathways and protein functions.
  • Agrochemical Synthesis: Potential intermediate in the development of new crop protection agents and herbicides.
  • Material Science Research: Investigated as a precursor for advanced organic electronic materials due to its complex conjugated structure.
  • Custom Synthesis & Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for client-specific synthesis projects.

Basic Information

Product Name 9-Bromo-2-Iodo-10-Methyl-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepine
CAS No. 1403766-75-5
Molecular Formula C₁₃H₁₀BrIN₂O
Molecular Weight 416.04 g/mol
Synonyms 9-Bromo-2-iodo-10-methyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine; Benzo[f]imidazo[1,2-d][1,4]oxazepine, 9-bromo-2-iodo-10-methyl-5,6-dihydro-; 1403766-75-5; 9-Br-2-I-10-Me-DH-Benzo[F]Imidazo-Oxazepine; 5,6-Dihydro-9-bromo-2-iodo-10-methylbenzo[f]imidazo[1,2-d][1,4]oxazepine
EINECS Contact for details

Quality Control

Our 9-Bromo-2-Iodo-10-Methyl-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepine is manufactured under strict quality control protocols to ensure batch-to-batch consistency and high purity for research applications. Each lot undergoes comprehensive analytical characterization, including HPLC for purity and NMR for structural confirmation. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting key specifications such as assay, identity, and impurity profiles.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed under an inert atmosphere (e.g., nitrogen or argon) after opening to prevent degradation. Keep away from incompatible materials.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (NMR) Conforms to structure
Purity (HPLC) ≥ 97.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%
Single Unknown Impurity (HPLC) ≤ 1.0%
Total Impurities (HPLC) ≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.